Presidential Plenary Session Sunday, April 17, 2016 9:00 a.m. to 12:00 p.m. Features the AAN’s premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2016. Moderator Lisa M. DeAngelis, MD, FAAN Chair, AAN Science Committee Presidential Lecture Brent C. James, MD Institute for Health Care Delivery Research at Intermountain Health Care, Salt Lake City, UT George C. Cotzias Lecture Endowed by Roche Pharmaceuticals. Josep O. Dalmau, MD, PhD University of Barcelona Barcelona, Spain University of Pennsylvania Philadelphia, PA Antibody Mediated Disorders of the Synapse Sidney Carter Award in Child Neurology Endowed by an Anonymous Donor. Elizabeth M. Berry-Kravis, MD, PhD Rush University Medical Center Chicago, IL Targeted Treatments for Fragile X Syndrome: Modifying the Translational Pathway Robert Wartenberg Lecture Jerome Engel Jr., MD, PhD, FAAN Reed Neurological Research Center UCLA, Los Angeles, CA What Can We Do For the Patient with Pharmacoresistant Epilepsy?
Sunday, April 17 Scientific Platform Sessions Meeting Schedule 1:00 p.m.–3:00 p.m. Scientific Platform Sessions S12: Neuromyelitis Optica and Autoimmune Encephalities 1:00 p.m. Presentation of the John Dystel Prize for Multiple Sclerosis Presented by the American Academy of Neurology and the National Multiple Sclerosis Society and made possible through a special contribution from the John Dystel Multiple Sclerosis Research Fund at the National Multiple Sclerosis Society. Recipient: Claudia F. Lucchinetti, MD, FAAN Rochester, MN 1:30 p.m. S12.003 Clinical Utility of Testing Cerebrospinal Fluid (CSF) for AQP4-IgG: A Guideline to Improve Physician Ordering of AQP4- IgG Diagnostic Test. —Masoud Majed, James Fryer, Andrew McKeon, Vanda Lennon, John Schmeling, Jessica Sagen, Sean Pittock 1:45 p.m. S12.004 Therapy of Neuromyelitis Optica Attacks: A Retrospective Study of 871 Attacks and 1153 Treatment Courses — Ingo Kleiter, Corinna Trebst 2:00 p.m. S12.005 Hormonal Exposures Relate to Clinical Phenotype in Women with Neuromyelitis Optica —Riley Bove, Liene Elsone, Enrique Alvarez, Nadja Borisow, Melissa Cortez, Farrah Mateen, Maureen Mealy, Jaime Sorum, Kerry Mutch, Sean Tobyne, Klemens Ruprecht, Guy Buckle, Michael Levy, Dean Wingerchuk, Paul Friedemann, Anne Cross, Brian Weinshenker, Anu Jacob, Eric Klawiter, Tanuja Chitnis 2:15 p.m. S12.006 MRI Correlates of Pediatric Neuromyelitis Optica Spectrum Disorder Syndromes —Jessica Hauser, Timothy Lotze 2:30 p.m. S12.007 Cross-Modal Plasticity Among Sensory Networks in Neuromyelitis Optica Spectrum Disorders —Filippo Savoldi, Maria Rocca, Paola Valsasina, Marta Radaelli, Paolo Preziosa, Giancarlo Comi, Andrea Falini, Massimo Filippi 2:45 p.m. S12.008 The Clinical Spectrum of Caspr2- Antibody Associated Disease —Agnes Sonderen, Helena Arino, Mar Petit-Pedrol, Frank Leypoldt, Peter Körtvelyessy, Eric Lancaster, Paul Wirtz, Marco Schreurs, Peter Sillevis Smitt, Francesc Graus, Josep Dalmau, Maarten Titulaer S13: Highlights in Sleep Medicine 1:00 p.m. Presentation of the Wayne A. Hening Sleep Medicine Investigator Award Sponsored by the American Academy of Neurology and endowed by UCB, Inc., Lilly USA, Elite Home Medical & Respiratory, Inc., Raleigh Neurology Associates, and friends of Dr. Wayne A. Hening. Recipient: Bryce Mander, PhD Berkeley, CA 1:15 p.m. Presentation of the Sleep Science Award Sponsored by the American Academy of Neurology and the AAN Sleep Section and endowed by Cephalon, Inc. Recipient: Juliane Winklemann, MD Palo Alto, CA 1:45 p.m. S13.004 Sleep Deprivation/Insomnia and Exposure to Street Lights in the American General Population — Maurice Ohayon, Cristina Milesi 2:00 p.m. S13.005 Human Sleep- and Wake-Promoting Networks Are Anticorrelated —Aaron Boes, Joel Geerling, David Fischer, Clifford Saper, Michael Fox 2:15 p.m. S13.006 Narcolepsy Symptomatology Evolution in a Longitudinal Study of a Cohort of Narcoleptic Family Members —Maurice Ohayon 2:30 p.m. S13.007 Association Between Sleep Problems and Brain Volume in the Elderly — Angeliki Tsapanou, Yian Gu, Jennifer Manly, Nicole Schupf, Nikolaos Scarmeas, Sandra Barral, Adam Brickman, Yaakov Stern 2:45 p.m. S13.008 Excessive GABAergic Activity in Striatal and Frontal Cortical Regions Rather Than Dopaminergic Functions Are Related to Daytime Sleepiness in Parkinson Disease —Nicolaas Bohnen, Melanie Beaulieu, Martijn Muller S14: Epilepsy: Antiepileptic Drugs and Epidemiology 1:00 p.m. S14.001 Importance of Monitoring Clobazam and N-Desmethylclobazam Levels in Treatment with Cannabidiol (CBD) for Epilepsy —Tyler Gaston, E Bebin, Jerzy Szaflarski 1:15 p.m. S14.002 Deconstructing Tolerance with Clobazam: Post Hoc Analyses from an Open-Label Extension Study —Barry Gidal, Robert Wechsler, Raman Sankar, Georgia Montouris, H. Steve White, James Cloyd, Guangbin Peng, David Tworek, Vivienne Shen, Jouko Isojarvi 1:30 p.m. S14.003 547-SSE-201 for Super-Refractory Status Epilepticus: Response and Relationship to Underlying Patient Characteristics —Stephen Kanes, Eric Rosenthal, Henrikas Vaitkevicius, Jan Claassen, Mark Wainwright, Ethan Hoffman, Mollie Baird, Mike Quirk, Helen Colquhoun 1:45 p.m. S14.004 Sabril Vision Study: Retinal Structure and Function in Adult Patients with Refractory Complex Partial Seizures (rCPS) Treated with Vigabatrin —Jouko Isojarvi, Robert Sergott, Chris Johnson, Kenneth Laxer, Robert Wechsler, Yekaterina Dribinsky, JoAnn Whittle, Ge Feng, Deborah Lee 2:00 p.m. S14.005 A Prospective Study of Add-On Anti-Epileptic Medication in Chronic Drug-Resistant Epilepsy —Jacqui-Lyn Saw, Nicholas Lawn, Josephine Chan, John Dunne 2:15 p.m. S14.006 Seizure Response to Cannabidiol in a State-Sponsored Open-Label Program —Jerzy Szaflarski, E Bebin, Jennifer DeWolfe, Leon Dure, Tyler Gaston, Krisztina Harsanyi, James Houston, Tony McGrath, Leslie Perry, Rani Singh, Ashley Thomas, Lawrence Ver Hoef 2:30 p.m. S14.007 Investigating the Effect of Cannabidiol on the EEG —Leslie Perry, Jerzy Szaflarski, E Bebin 2:45 p.m. S14.008 Prevalence and Incidence of Epilepsy in the Elderly: The Cardiovascular Health Study —Hyunmi Choi, Alison Pack, Mitchell Elkind, W. T. Longstreth, Frankline Onchiri 1:00 p.m.–2:00 p.m. I Navigating the World of Mobile Health Director: Eric Anderson, MD, PhD, Decatur, GA Health & Wellness Physical Exercise and Cognitive Training in Neurology— Application in Aging & Neurodegenerative Disease Director: Ergun Y. UC, MD, Iowa City, IA 1:00 p.m.–3:00 p.m. S12 Neuromyelitis Optica and Autoimmune Encephalities S13 Highlights in Sleep Medicine S14 Epilepsy: Antiepileptic Drugs and Epidemiology Real World of NeurologyAsk the Expert: ICD-10-CM Director: Korwyn William, MD, PhD, Phoenix, AZ C71 Dementia Update: Imaging Modalities and CTE Director: John C. Morris, MD, FAAN, St. Louis, MO C72 Neurology Update I Director: Joseph E. Safdieh, MD, FAAN, New York, NY C73 Quality Improvement in Practice Director: Christopher Bever, Jr., MD, MBA, FAAN, Baltimore, MD C74 Child Neurology II Director: Jonathan W. Mink, MD, PhD, FAAN, Rochester, NY C75 Myelopathies I Director: Benjamin M. Greenberg, MD, FAAN, Dallas, TX C76 Infections of the Nervous System II Director: Tracey Cho, MD, Boston, MA C77 Movement Disorders for the General Neurologist II Director: Susan Fox, MD, Toronto, ON C78 Evaluation and Management of Autonomic Disorders I Director: Paola Sandroni, MD, PhD, FAAN, Rochester, MN C79 Emergency Neurology Topics: Status Epilepticus and Pediatric Neurology Emergencies Director: Laurie Gutmann, MD, FAAN, Iowa City, IA C80 Now You See It, Now You Know It—Pathognomonic Neuroophthalmology Findings Director: Wayne T. Cornblath, MD, FAAN, Ann Arbor, MI C81 Functional Neurologic Disorders I Director: Janis Miyasaki, MD, FAAN, Edmonton, AB Fast and easy registration · AAN.com/view/AM16 57
Change language